Our industry has been shaped by an ever-changing landscape, with emerging science disrupting the status quo to offer new hope for patients with unmet medical needs. Cell and gene therapies (CT/GT products) are the latest wave of advanced technologies shaping the face of the modern-day arena. The CT/GT product development pathway is not a straight line and presents ground-breaking opportunities and significant challenges. On the outset, many find themselves in uncharted territories seeking guidance and precedent where there is none.
During this session, speakers will reflect on some the cross-functional opportunities and challenges they faced in early development, in addition to discussing future milestones and anticipated obstacles along the way. This session will offer attendees a real-world perspective, and approaches on the development of CT/GT products from peers who have been in their shoes.

Ability Level: All

Session ID: 503591